-+ 0.00%
-+ 0.00%
-+ 0.00%

Kasvu Therapeutics raises EUR 30 million in funding round backed by Finnish Industry Investment Oy

PUBT·09/24/2026 08:23:30
Listen to the news
Kasvu Therapeutics raises EUR 30 million in funding round backed by Finnish Industry Investment Oy
  • Kasvu Therapeutics raised EUR 30 million in a private financing round led by Hadean Ventures, with Finnish Industry Investment Oy participating.
  • Helsinki-founded drug developer formed in 2023, targeting depression and other brain disorders using research from the University of Helsinki.
  • Programme aims to replicate psychedelic-linked antidepressant benefits without hallucinogenic effects.
  • Proceeds to advance the lead candidate into clinical development through its first depression trial, expected to start in 2H 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Finnish Industry Investment Oy published the original content used to generate this news brief on September 24, 2026, and is solely responsible for the information contained therein.